Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 15, Pages 12192
Publisher
MDPI AG
Online
2023-07-31
DOI
10.3390/ijms241512192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer
- (2021) Jin Moriyama et al. SURGERY TODAY
- Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
- (2021) Wei Xu et al. Frontiers in Oncology
- PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
- (2021) Yoon-Koo Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
- (2021) Xiaotian Zhang et al. LANCET ONCOLOGY
- The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy
- (2020) Ziyu Li et al. Gastric Cancer
- Peripheral Blood Platelet–Lymphocyte Ratio Is Good Predictor of Chemosensitivity and Prognosis in Gastric Cancer Patients
- (2020) Yuka Ohe et al. Cancer Management and Research
- Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
- (2020) Ziyu Li et al. Science Advances
- CA19-9 is a significant prognostic marker of patients with stage III gastric cancer
- (2020) Yuichi Kambara et al. EJSO
- Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer
- (2020) Yong-He Chen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Wnt/β-catenin signaling axis is required for TFEB-mediated gastric cancer metastasis and epithelial-mesenchymal transition
- (2020) Shuxuan Li et al. MOLECULAR CANCER RESEARCH
- Gastric cancer
- (2020) Elizabeth C Smyth et al. LANCET
- Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy
- (2019) Li Chen et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis
- (2018) Ziyu Li et al. PLoS One
- Clinicopathological and prognostic significance of high circulating lymphocyte ratio in patients receiving neoadjuvant chemotherapy for advanced gastric cancer
- (2018) Yang Li et al. Scientific Reports
- Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer
- (2018) Susan Tsai et al. ANNALS OF SURGERY
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response
- (2016) Bryan J. Schneider et al. CLINICAL CANCER RESEARCH
- Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project
- (2016) Takeshi Sano et al. Gastric Cancer
- Japanese gastric cancer treatment guidelines 2014 (ver. 4)
- (2016) Gastric Cancer
- Prognostic value of CA 19-9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma
- (2016) Ban Seok Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review
- (2015) G. Colloca et al. Clinical & Translational Oncology
- Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
- (2015) Zhipeng Sun et al. World Journal of Surgical Oncology
- PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway
- (2014) Xiaofang Xing et al. ANTI-CANCER DRUGS
- Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: A prospective, hypothesis driven study on patients with locally advanced rectal cancer
- (2014) Jeroen Buijsen et al. RADIOTHERAPY AND ONCOLOGY
- Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer
- (2013) Jiuchang Xiao et al. TUMOR BIOLOGY
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
- (2011) Marc Ychou et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
- (2010) Christoph Schuhmacher et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started